ID   CN37_RAT                Reviewed;         420 AA.
AC   P13233; Q4V796; Q64575;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   29-MAY-2024, entry version 171.
DE   RecName: Full=2',3'-cyclic-nucleotide 3'-phosphodiesterase {ECO:0000305};
DE            Short=CNP;
DE            Short=CNPase;
DE            EC=3.1.4.37 {ECO:0000250|UniProtKB:P06623};
DE   Flags: Precursor;
GN   Name=Cnp {ECO:0000312|RGD:2368}; Synonyms=Cnp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3040924; DOI=10.1523/jneurosci.07-09-02703.1987;
RA   Bernier L., Alvarez F., Norgard E.M., Raible D.W., Mentaberry A.,
RA   Schembri J.G., Sabatini D.D., Colman D.R.;
RT   "Molecular cloning of a 2',3'-cyclic nucleotide 3'-phosphodiesterase: mRNAs
RT   with different 5' ends encode the same set of proteins in nervous and
RT   lymphoid tissues.";
RL   J. Neurosci. 7:2703-2710(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7932861; DOI=10.1002/jnr.490380302;
RA   Gravel M., DeAngelis D., Braun P.E.;
RT   "Molecular cloning and characterization of rat brain 2',3'-cyclic
RT   nucleotide 3'-phosphodiesterase isoform 2.";
RL   J. Neurosci. Res. 38:243-247(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 1-15; 20-63; 80-87; 94-112; 117-150; 155-202; 204-216;
RP   224-274; 283-368 AND 379-410, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [5]
RP   ISOPRENYLATION AT CYS-417, AND MUTAGENESIS OF CYS-417.
RX   PubMed=7884818; DOI=10.1002/jnr.490390405;
RA   De Angelis D.A., Braun P.E.;
RT   "Isoprenylation of brain 2',3'-cyclic nucleotide 3'-phosphodiesterase
RT   modulates cell morphology.";
RL   J. Neurosci. Res. 39:386-397(1994).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-227; SER-239;
RP   THR-262 AND SER-358, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   STRUCTURE BY NMR OF 184-398 IN COMPLEX WITH PHOSPHATE, AND MUTAGENESIS OF
RP   HIS-250; THR-252; HIS-329; THR-331 AND GLY-344.
RX   PubMed=12947117; DOI=10.1074/jbc.m305176200;
RA   Kozlov G., Lee J., Elias D., Gravel M., Gutierrez P., Ekiel I., Braun P.E.,
RA   Gehring K.;
RT   "Structural evidence that brain cyclic nucleotide phosphodiesterase is a
RT   member of the 2H phosphodiesterase superfamily.";
RL   J. Biol. Chem. 278:46021-46028(2003).
CC   -!- FUNCTION: Catalyzes the formation of 2'-nucleotide products from 2',3'-
CC       cyclic substrates (By similarity). May participate in RNA metabolism in
CC       the myelinating cell, CNP is the third most abundant protein in central
CC       nervous system myelin (By similarity). {ECO:0000250|UniProtKB:P06623,
CC       ECO:0000250|UniProtKB:P16330}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a nucleoside 2',3'-cyclic phosphate + H2O = a nucleoside 2'-
CC         phosphate + H(+); Xref=Rhea:RHEA:14489, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:66954, ChEBI:CHEBI:78552; EC=3.1.4.37;
CC         Evidence={ECO:0000250|UniProtKB:P06623};
CC   -!- SUBUNIT: Exists as monomers and homodimers.
CC       {ECO:0000250|UniProtKB:P16330}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P16330}; Lipid-
CC       anchor {ECO:0000250|UniProtKB:P16330}. Melanosome
CC       {ECO:0000250|UniProtKB:P09543}. Note=Firmly bound to membrane
CC       structures of brain white matter. {ECO:0000250|UniProtKB:P16330}.
CC   -!- SIMILARITY: Belongs to the 2H phosphoesterase superfamily. CNPase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA40939.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAA40939.1; Type=Miscellaneous discrepancy; Note=Sequencing errors.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M18630; AAA40939.1; ALT_SEQ; mRNA.
DR   EMBL; L16532; AAA64429.1; -; mRNA.
DR   EMBL; BC098066; AAH98066.1; -; mRNA.
DR   PIR; A45670; A45670.
DR   PIR; I56577; I56577.
DR   RefSeq; NP_036941.1; NM_012809.2.
DR   PDB; 2ILX; NMR; -; A=184-398.
DR   PDBsum; 2ILX; -.
DR   AlphaFoldDB; P13233; -.
DR   BMRB; P13233; -.
DR   SMR; P13233; -.
DR   BioGRID; 247315; 7.
DR   IntAct; P13233; 3.
DR   MINT; P13233; -.
DR   STRING; 10116.ENSRNOP00000023875; -.
DR   CarbonylDB; P13233; -.
DR   iPTMnet; P13233; -.
DR   PhosphoSitePlus; P13233; -.
DR   SwissPalm; P13233; -.
DR   jPOST; P13233; -.
DR   PaxDb; 10116-ENSRNOP00000023875; -.
DR   Ensembl; ENSRNOT00000103289.1; ENSRNOP00000080276.1; ENSRNOG00000017496.5.
DR   Ensembl; ENSRNOT00055057794; ENSRNOP00055047679; ENSRNOG00055033417.
DR   Ensembl; ENSRNOT00060048548; ENSRNOP00060040463; ENSRNOG00060027890.
DR   Ensembl; ENSRNOT00065056380; ENSRNOP00065046395; ENSRNOG00065032747.
DR   GeneID; 25275; -.
DR   KEGG; rno:25275; -.
DR   UCSC; RGD:2368; rat.
DR   AGR; RGD:2368; -.
DR   CTD; 1267; -.
DR   RGD; 2368; Cnp.
DR   eggNOG; KOG2401; Eukaryota.
DR   GeneTree; ENSGT00510000048410; -.
DR   HOGENOM; CLU_039178_0_0_1; -.
DR   InParanoid; P13233; -.
DR   OMA; DAYKINP; -.
DR   OrthoDB; 5489998at2759; -.
DR   PhylomeDB; P13233; -.
DR   TreeFam; TF332157; -.
DR   BRENDA; 3.1.4.37; 5301.
DR   BRENDA; 3.1.4.58; 5301.
DR   EvolutionaryTrace; P13233; -.
DR   PRO; PR:P13233; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000017496; Expressed in Ammon's horn and 20 other cell types or tissues.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005902; C:microvillus; IDA:RGD.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
DR   GO; GO:0043209; C:myelin sheath; IDA:UniProtKB.
DR   GO; GO:0035748; C:myelin sheath abaxonal region; IDA:RGD.
DR   GO; GO:0035749; C:myelin sheath adaxonal region; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0031143; C:pseudopodium; IDA:RGD.
DR   GO; GO:0004113; F:2',3'-cyclic-nucleotide 3'-phosphodiesterase activity; IDA:RGD.
DR   GO; GO:0030551; F:cyclic nucleotide binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0009214; P:cyclic nucleotide catabolic process; IEA:InterPro.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permeability; IMP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; ISO:RGD.
DR   Gene3D; 3.90.1740.10; 2',3'-cyclic nucleotide 3'-phosphodiesterase superfamily; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR008431; CNPase.
DR   InterPro; IPR047325; CNPase_cat.
DR   InterPro; IPR009097; Cyclic_Pdiesterase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10156; 2',3'-CYCLIC-NUCLEOTIDE 3'-PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR10156:SF0; 2',3'-CYCLIC-NUCLEOTIDE 3'-PHOSPHODIESTERASE; 1.
DR   Pfam; PF13671; AAA_33; 1.
DR   Pfam; PF05881; CNPase; 1.
DR   PIRSF; PIRSF000970; CNPase; 1.
DR   SUPFAM; SSF55144; LigT-like; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Hydrolase; Lipoprotein; Membrane;
KW   Methylation; Phosphoprotein; Prenylation; Reference proteome; RNA-binding.
FT   CHAIN           1..417
FT                   /note="2',3'-cyclic-nucleotide 3'-phosphodiesterase"
FT                   /id="PRO_0000089963"
FT   PROPEP          418..420
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000422299"
FT   ACT_SITE        250
FT                   /note="Proton acceptor"
FT   ACT_SITE        329
FT                   /note="Proton donor"
FT   BINDING         252
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         331
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09543"
FT   MOD_RES         110
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P16330"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         262
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         417
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000305"
FT   LIPID           417
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:7884818"
FT   MUTAGEN         250
FT                   /note="H->L: Reduces activity 15000-fold."
FT                   /evidence="ECO:0000269|PubMed:12947117"
FT   MUTAGEN         252
FT                   /note="T->A: Reduces activity 100-fold."
FT                   /evidence="ECO:0000269|PubMed:12947117"
FT   MUTAGEN         329
FT                   /note="H->L: Reduces activity 15000-fold."
FT                   /evidence="ECO:0000269|PubMed:12947117"
FT   MUTAGEN         331
FT                   /note="T->A: Reduces activity 700-fold."
FT                   /evidence="ECO:0000269|PubMed:12947117"
FT   MUTAGEN         344
FT                   /note="G->A: Alters secondary structure and lowers
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12947117"
FT   MUTAGEN         417
FT                   /note="C->S: Abolishes binding to myelin."
FT                   /evidence="ECO:0000269|PubMed:7884818"
FT   STRAND          187..193
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           195..213
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           216..219
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           222..225
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          229..231
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           237..240
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   TURN            257..260
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           264..268
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           271..276
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          280..290
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          295..299
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           303..307
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          313..315
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          317..320
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          326..331
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   HELIX           340..355
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          361..366
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          369..373
FT                   /evidence="ECO:0007829|PDB:2ILX"
FT   STRAND          379..396
FT                   /evidence="ECO:0007829|PDB:2ILX"
SQ   SEQUENCE   420 AA;  47268 MW;  83001BBA2C057826 CRC64;
     MSTSFARKSH TFLPKIFFRK MSSSGAKDKP ELQFPFLQDE DTVATLHECK TLFILRGLPG
     SGKSTLARLI VEKYHNGTKM VSADAYKIIP GSRADFSEEY KRLDEDLAGY CRRDIRVLVL
     DDTNHERERL DQLFEMADQY QYQVVLVEPK TAWRLDCAQL KEKNQWQLSL DDLKKLKPGL
     EKDFLPLYFG WFLTKKSSET LRKAGQVFLE ELGNHKAFKK ELRHFISGDE PKEKLDLVSY
     FGKRPPGVLH CTTKFCDYGK ATGAEEYAQQ DVVRRSYGKA FKLSISALFV TPKTAGAQVV
     LNEQELQLWP SDLDKPSSSE SLPPGSRAHV TLGCAADVQP VQTGLDLLEI LQQVKGGSQG
     EEVGELPRGK LYSLGKGRWM LSLAKKMEVK AIFTGYYGKG KPVPVHGSRK GGAMQICTII
//
